Virtual Public Meeting Generic Drug User Fee Amendments – A Perspective for GDUFA III
On Tuesday from 9:00-3:00 PM, the FDA held a virtual public meeting to obtain initial input from federal agencies, healthcare organizations, industry trade associations and other stakeholders in general on the reauthorization preparations for the third iteration of GDUFA. It is not known whether FDA will provide a link to the virtual program, as it […]
